Pacific Biosciences of California, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €256.54M +5.8% -€97.24M -3.0% -37.9% +0.034 pp N/A N/A
    (estimated) €242.44M +22.8% -€100.20M -13.9% -41.3% +0.18 pp N/A N/A
    (estimated) €197.39M +24.6% -€116.39M -13.6% -59.0% +0.26 pp N/A N/A
    (estimated) €158.39M +16.0% -€134.68M -71.7% -85.0% +2.6 pp N/A N/A
    (estimated) €136.51M +3.9% -€476.46M +80.3% -349.0% -1.5 pp N/A N/A
    €131.37M -23.2% -€264.29M +1.0% -201.2% -0.48 pp -€170.48M -20.2% -129.8% -0.049 pp
    €171.03M +56.3% -€261.63M -2.4% -153.0% +0.92 pp -€213.52M +1.6% -124.8% +0.67 pp
    €109.44M -1.7% -€268.04M +73.4% -244.9% -1.1 pp -€210.07M +134.0% -192.0% -1.1 pp
    €111.32M +65.4% -€154.57M -716.3% -138.9% -1.8 pp -€89.77M -612.4% -80.6% -1.1 pp
    €67.29M -13.2% €25.08M -137.8% 37.3% +1.2 pp €17.52M -127.2% 26.0% +1.1 pp
    €77.53M +15.6% -€66.38M -24.1% -85.6% +0.45 pp -€64.38M +16.9% -83.0% -0.0091 pp
    €67.06M -15.9% -€87.48M +11.3% -130.4% -0.32 pp -€55.08M +13.1% -82.1% -0.21 pp
    €79.72M +3.0% -€78.63M +24.0% -98.6% -0.17 pp -€48.69M -4.4% -61.1% +0.048 pp
    €77.37M -2.2% -€63.44M +134.7% -82.0% -0.48 pp -€50.94M +33.1% -65.8% -0.17 pp
    €79.14M +53.1% -€27.04M -52.1% -34.2% +0.75 pp -€38.28M -10.0% -48.4% +0.34 pp
    €51.68M +115.0% -€56.43M -16.6% -109.2% +1.7 pp -€42.53M +72.4% -82.3% +0.20 pp
    €24.04M +8.5% -€67.63M -16.1% -281.4% +0.82 pp -€24.67M -61.5% -102.6% +1.9 pp
    €22.16M -23.3% -€80.57M -13.6% -363.6% -0.41 pp -€64.07M -19.8% -289.1% -0.12 pp
    €28.88M +1,922.9% -€93.30M -22.0% -323.0% +81 pp -€79.91M -19.7% -276.7% +67 pp
    €1.43M +1,140.0% -€119.55M +59.8% -8,373.1% +570 pp -€99.57M +67.6% -6,973.5% +450 pp
    €115.15K -85.0% -€74.81M +100.4% -64,965.2% -600 pp -€59.42M +113.7% -51,600.7% -480 pp
    €768.51K -€37.32M -4,856.2% -€27.81M -3,618.2%

    Notifications